The virion protein 40 (VP40) and nucleoprotein (NP) of Ebola (EBOV) and Marburg viruses (MARV) play key roles during virion assembly and egress. The ability to detect interactions between VP40-VP40, VP40-NP, and NP-NP and follow these complexes as they traffic through mammalian cells would enhance our understanding of the molecular events leading to filovirus assembly and budding, and provide new insights into filovirus replication and pathogenesis. Here, we successfully employed a bimolecular complementation (BiMC) approach to visualize interactions between EBOV and MARV VP40-VP40, NP-NP, and VP40-NP proteins and localize these protein complexes in mammalian cells using confocal microscopy. We demonstrate that VP40-VP40 complexes localized predominantly at the plasma membrane, whereas VP40-NP and NP-NP complexes displayed a more dispersed pattern throughout the cytoplasm. As expected based on previous findings, efficient interactions between EBOV or MARV VP40-VP40 proteins were independent of L-domains PTAPPEY and PPPY, respectively. In contrast, the formation of EBOV or MARV VP40-VP40 complexes was dependent on the previously characterized LPLGVA and LPLGIM motifs of EBOV and MARV VP40 proteins, respectively, indicating that these motifs are important for VP40 oligomerization and subsequent budding. These results highlight the feasibility and usefulness of the BiMC approach as a strategy to further characterize both filovirus protein interactions as well as filovirus-host interactions in real time in the natural environment of the cell.
Ebola (EBOV) and Marburg viruses (MARV) belong to the Filoviridae family and are the causative agents of rapidly progressive, hemorrhagic fevers with high mortality rates among humans and nonhuman primates [1] . To date, there is no approved vaccine nor pharmacological therapy available to protect or treat individuals infected with filoviruses [1, 2] . Filoviruses are enveloped, nonsegmented, negative-strand RNA viruses with 19-kilobase genomes containing 7 sequentially arranged genes. Genes encode 7 structural proteins: nucleoprotein (NP), virion proteins (VP35, VP40, VP30, and VP24), polymerase protein, transmembrane glycoprotein (GP), and for all EBOV species, a nonstructural, secreted glycoprotein (sGP) is also encoded [1, 3] . VP40 is necessary for the redistribution of the nucleocapsids from cytoplasmic inclusions to the sites of particle assembly and budding [3] , as well as for recruitment of GP to the VP40-positive peripheral clusters where budding takes place [4] .
Expression of VP40 alone in mammalian cells results in egress of filamentous virus-like particles (VLPs) that closely resemble authentic filovirus particles [5] [6] [7] [8] . Late (L) domains within EBOV VP40 and within MARV VP40 (mVP40) and NP play an important role in the budding process of filoviruses by recruiting host factors to promote efficient egress [3, [9] [10] [11] . Indeed, the efficient production of filovirus particles [6, [12] [13] [14] [15] [16] . In addition to L-domains, oligomerization of VP40 was shown to be important for intracellular transport, membrane binding, and virus particle formation and egress [17, 18] . In addition to VP40, filovirus GP and NP proteins were shown to contribute to efficient egress of filovirus particles [4, 6, 7, 10, 14, [19] [20] [21] . For example, coexpression of EBOV NP (eNP) or GP with eVP40 significantly enhanced release of VLPs from mammalian cells [21, 22] , and MARV NP (mNP) was shown recently to enhance budding of MARV by recruiting host Tsg101 via a C-terminal PSAP L-domain motif [10] . Thus, coordinated interactions among filovirus proteins are essential for efficient virion assembly and egress. A better understanding of the molecular interplay among filoviral proteins in mammalian cells is warranted and may facilitate the development of novel antiviral therapeutics.
To begin to address gaps in our understanding of intracellular interaction sites and trafficking patterns of filovirus protein complexes in the cell, we successfully employed a bimolecular complementation (BiMC) approach [23] [24] [25] to detect, visualize, and map wild-type (WT) and mutant filovirus protein-protein interactions in live mammalian cells. Indeed, this approach was used to visualize VP40-VP40, VP40-NP, and NP-NP interactions for both EBOV and MARV. The BiMC technique is based on an underlying principle that a reporter protein (eg, enhanced yellow fluorescent protein [EYFP] used in this study) can be split into 2 separate inactive components, which are then genetically fused to potentially interacting protein partners (eg, filovirus proteins). An interaction between these partners results in essentially irreversible reconstitution of an active EYFP, allowing for direct visualization and quantitation in living cells [23] [24] [25] . Advantages of the BiMC technique are that it enables characterization of protein-protein interactions in the natural cellular environment and allows for the detection and recording of weak or transient interactions [24, 25] . Our findings provide proof of principle of the feasibility of using the BiMC approach to map the intracellular locations and trafficking patterns of filovirus protein complexes in live cells.
MATERIALS AND METHODS
Cells, Antibodies, and Plasmids 293T (human embryonic kidney) cells were maintained in Dulbecco's modified Eagle medium (DMEM; Invitrogen) supplemented with 10% fetal calf serum (FCS; Hyclone) and 1 3 penicillin-streptomycin (Invitrogen) at 5% CO 2 at 37°C. Rabbit antiserum against eVP40 was described previously [26] . Mouse monoclonal antibody against FLAG epitope (SigmaAldrich) was used according to the manufacturer's instructions. Plasmids eVP40-WT, eVP40-DLPLGVA, mVP40-WT (kindly provided by S. Becker, Marburg, Germany), mVP40-DLPLGIM and pCAGGS-eNP were previously described [21, 26] . Plasmid pCAGGS-mNP was kindly provided by S. Becker (Marburg, Germany), via C. Basler (Mt. Sinai Med. Ctr., New York) and E. Muehlberger (Boston Univ., Boston MA). Sequences of all EBOV viral proteins were derived from Zaire EBOV strain Zaire 1995 (GenBank accession No: AY354458.1), and those of all MARV viral proteins were derived from Lake Victoria MARV strain Musoke (GenBank accession No: NC_001608). Plasmid pCS2-containing full-length Venus EYFP was generously provided by R. Eisenberg and G. Cohen (University of Pennsylvania School of Dental Medicine). All recombinant plasmids containing WT or mutant VP40 or NP fused with the N-or C-termini of EYFP were constructed by standard polymerase chain reaction (PCR) and cloning techniques using the pCAGGS expression vector.
Transfection and Confocal Microscopy
Transfection and confocal microscopy were performed as previously described [26] . Human 293T cells were grown on glass coverslips in 6-well plates and were transfected with the indicated plasmids using Lipofectamine reagent (Invitrogen). At 4 hours posttransfection (pt), cell culture supernatant was replaced with fresh DMEM containing 10% FCS. At 24 hours pt, cells were washed twice with phosphate-buffered saline (PBS; pH 7.2) and fixed with cold methanol-acetone (1:1, v/v) for 10 minutes at room temperature. Cells were washed as described above and subsequently stained with 4#, 6#-diamidino-2-phenylindole (DAPI) for 10 minutes at room temperature. Cells were washed 4 times with PBS and affixed to glass slides with Prolong Antifade (Invitrogen/Molecular Probes). Slides were viewed by an LSM-510 Meta confocal microscope (Carl Zeiss).
VLP Budding Assay and Western Blotting
Transfection, VLP isolation, and Western blotting were performed as described previously [26] . Equal amounts of proteins in cell extracts and purified VLPs were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and then analyzed by Western blotting as described previously [26] .
RESULTS AND DISCUSSION

Generation and Expression of EYFP-Fusion Proteins
The basic premise of the BiMC strategy is illustrated in Figure 1 [23] [24] [25] . A series of plasmids were constructed to express EBOV or MARV VP40 or NP proteins joined in-frame to either the N-terminal fragment of EYFP (YN or NYFP), or the C-terminal fragment of EYFP (YC or CYFP) (Figure 1) . Expression of all EYFP-filovirus fusion proteins in transfected cells was confirmed by Western blotting using appropriate antisera (Figure 2) . Fusion of the EYFP fragments to the N-termini of WT or mutant VP40 proteins did not appear to alter protein expression, nor the well-characterized, L-domain-dependent budding properties of these viral matrix proteins ( Figure 2) . As an example, CYFPeVP40-WT and CYFP-eVP40-DPT/PY were both expressed in cell extracts ( Figure 2) ; however, only CYFP-eVP40-WT was able to bud efficiently as a VLP (Figure 2 ), whereas budding of CYFPeVP40-DPT/PY L-domain mutant was defective (Figure 2 ). Unmodified eVP40-WT (Figure 2 ) was included as a control. Similar findings were obtained using mVP40-WT (control), CYFPmVP40-WT, and CYFP-mVP40-DPPPY (Figure 2 ). 
VP40-VP40 Interactions
First, we sought to detect a VP40-VP40 interaction using the BiMC assay. We used fusion proteins expressing WT and deletion mutants of both eVP40 and mVP40 (Figure 3 ). It should be noted that human 293T cells singly transfected with any of the EYFP fusion plasmids yielded no fluorescent signal (Liu and Harty, data not shown). Human 293T cells were cotransfected with NYFP-eVP40-WT 1 CYFP-eVP40-WT, and the cells were examined by confocal microscopy at 24 hours pt for EYFP fluorescence (Figure 3) . A strong, reproducible EYFP signal was observed indicative of an eVP40-eVP40 interaction ( Figure 3 ).
As expected, the eVP40-eVP40 complexes were enriched at the cell surface and displayed a pattern of filamentous-like membrane projections (Figure 3) . A similar pattern was observed in cells expressing NYFP-mVP40-WT 1 CYFP-mVP40-WT (Figure 3) . Notably, in addition to the cell surface fluorescence, we consistently observed a strong fluorescent signal in a perinuclear pattern in cells expressing NYFP-mVP40-WT 1 CYFP-mVP40-WT, but not in cells expressing NYFP-eVP40-WT 1 CYFP-eVP40-WT (Liu and Harty, data not shown). Whether this reproducible difference in the fluorescent patterns of eVP40 and mVP40 complexes represents distinct intracellular transport pathways for these complexes, or distinct homo-oligomerization properties of eVP40 and mVP40 remains to be determined.
Next, we assessed the ability of 2 different VP40 deletion mutants to interact with WT forms of both EBOV and MARV VP40. We reasoned that the L-domain deletion mutants of eVP40 (eVP40-DPT/PY) and mVP40 (mVP40-DPPPY) should still interact with their corresponding WT VP40 partner and display a fluorescent pattern similar to that observed for VP40-VP40 WT complexes, because the L-domains function in host protein recruitment. In contrast, use of the previously described DLPLGVA and DLPLGIM mutants of eVP40 and mVP40, respectively would likely alter the pattern of fluorescence observed for VP40-VP40 WT complexes, because these and adjacent sequences appear to be required for efficient oligomerization, membrane localization, and egress of VP40 [18, 26] . Indeed, NYFP-eVP40-WT 1 CYFP-eVP40-DPT/PY complexes ( Figure 3 ) and NYFP-mVP40-WT 1 CYFP-mVP40-DPPPY complexes ( Figure 3) were enriched at the cell surface yielding a fluorescent signal that was slightly reduced, but overall similar to that described for EBOV and MARV VP40-WT complexes. In contrast, cells expressing CYFP-eVP40-DLPLGVA 1 NYFPeVP40-WT ( Figure 3 ) revealed a highly punctate pattern of fluorescence that was dramatically different from that observed for eVP40-WT complexes (panel a). Interestingly, the mVP40-DLPLGIM mutant also retained the ability to interact with mVP40-WT ( Figure 3) ; however, the pattern of fluorescence exhibited by these complexes was only slightly punctate, with more predominant staining at the plasma membrane (Figure 3) . Notably absent however was the presence of abundant filamentous membrane projections clearly visible for mVP40-WT complexes (Figure 3) . Lastly, virtually no fluorescent signal was observed in cells coexpressing either NYFP-eVP40-DLPLGVA 1 CYFP-eVP40-DLPLGVA (Figure 3) , or NYFPmVP40-DLPLGIM 1 CYFP-mVP40-DLPLGIM (Figure 3 ), indicating that these sequences are critical for eVP40 and mVP40 self-interactions.
In sum, these findings using the BiMC approach correlated well with our previous characterization of the eVP40-DLPLGVA and mVP40-DLPLGIM mutants [26] , suggesting that these sequences are indeed critical for VP40 self-interactions and intracellular localization. In further support of these findings, Hoenen et al reported recently that mutating residues W95 or L96 (within the LPLGVA motif) of eVP40 resulted in impaired oligomerization of eVP40, defective intracellular transport to the plasma membrane, and decreased egress of eVP40 VLPs [18] .
VP40-NP and NP-NP Interactions
Next, we sought to determine whether the BiMC approach could be used to detect VP40-NP and NP-NP interactions and visualize these protein complexes in mammalian cells. VP40-NP interactions have been shown to be important for both virus assembly and enhanced budding of VLPs and virus particles [8, 10, 21, 27] , whereas NP-NP interactions are essential for RNP assembly in the cytoplasm of infected cells [27] . Human 293T cells were cotransfected with plasmids expressing NYFPeNP 1 CYFP-eNP (Figure 4 ), NYFP-eNP 1 CYFP-eVP40-WT (panel b), NYFP-mNP 1 CYFP-mNP (panel c), or NYFPmVP40-WT 1 CYFP-mNP (panel d), and fluorescent cells were observed at 24 hours posttransfection. We observed bright EYFP fluorescence in a predominantly diffuse, cytoplasmic pattern for both VP40-NP and NP-NP complexes (Figure 4) , with a low level of staining for VP40-NP complexes at the plasma membrane (data not shown). The intracellular patterns observed for VP40-NP and NP-NP complexes for both EBOV and MARV ( Figure 4) were clearly distinct from those observed for VP40-VP40 complexes (Figure 3 ). In addition, we observed that the eVP40-DLPLGVA and mVP40-DLPLGIM deletion mutants interacted with eNP and mNP, respectively, yielding a similar pattern of cytoplasmic fluorescence and suggesting that the LPLGVA and LPLGIM sequences are not essential for the formation of VP40-NP complexes (Liu and Harty, data not shown).
Notably, the diffuse cytoplasmic pattern of fluorescence observed for both NYFP-eNP 1 CYFP-eNP ( Figure 4 ) and NYFP-mNP 1 CYFP-mNP (Figure 4) , differed from the more speckled-type pattern observed when antibodies were used to detect NP [28] . Whether this difference reflects the location of the EYFP fragment at the N-terminus of eNP and mNP remains to be determined. It should be noted that the addition of increasing amounts of unmodified eNP or mNP to cells coexpressing NYFP-eNP 1 CYFP-eNP or NYFP-mNP 1 CYFP-mNP, respectively, did not significantly alter the diffuse We have shown previously that overexpression of eVP40-WT was able to rescue the budding defective phenotype of deletion mutant eVP40-DLPLGVA, resulting in the egress of VLPs containing both eVP40-WT and eVP40-DLPLGVA [26] . Thus, it was of interest to determine whether overexpression of unmodified eVP40-WT would alter the intracellular localization of NYFP-eVP40-WT 1 CYFP-eVP40-DLPLGVA complexes ( Figure 3 ) to more closely resemble that observed for NYFPeVP40-WT 1 CYFP-eVP40-WT complexes (Figure 3 ). Toward this end, human 293T cells were cotransfected with constant amounts of NYFP-eVP40-WT 1 CYFP-eVP40-DLPLGVA plasmids along with increasing amounts (0.0, 0.3, 0.6, 1.2, and 2.0 lg) of unmodified eVP40-WT plasmid ( Figure 5 ). In a control dish, 2.0 lg of pCAGGS empty vector was added ( Figure 5 ). Consistent with results described in Figure 3 , the fluorescent pattern exhibited by NYFP-eVP40-WT 1 CYFPeVP40-DLPLGVA complexes in the absence of excess eVP40-WT was primarily punctate in nature, with little to no plasma membrane staining ( Figure 5 ). Interestingly, on cotransfection of increasing amounts of eVP40-WT plasmid, the intracellular localization of the NYFP-eVP40-WT 1 CYFP-eVP40-DLPLGVA complexes shifted to a more plasma membrane-enriched pattern ( Figure 5) . Indeed, the overall intensity and sharpness of the plasma membrane staining exhibited by the NYFP-eVP40-WT 1 CYFP-eVP40-DLPLGVA complexes increased in a dosedependent manner. In stark contrast, cotransfection of 2.0 lg of pCAGGS empty vector did not alter the fluorescent pattern formed by NYFP-eVP40-WT 1 CYFP-eVP40-DLPLGVA complexes ( Figure 5 ). Thus, these results suggest that expression of excess eVP40-WT mediated the mobilization of the existing eVP40-WT/eVP40-DLPLGVA complexes from the perinuclear aggregates to the plasma membrane, likely resulting in enhanced release and rescue of budding VLPs observed previously [26] .
In sum, our results using the BiMC approach provide proof of principle that this strategy can be used to dissect further the interplay not only between filovirus protein-protein interactions, but also filovirus-host interactions (Liu and Harty, manuscript submitted) that are crucial for virus replication, budding, and pathogenesis. Importantly, detection and mapping of these protein-protein interactions and complexes will be assessed in real time in the natural biological environment of the cell. Future studies will undoubtedly lead to new insights into the mechanistic similarities and differences between EBOV and MARV replication, and may aid in the identification of novel targets for the development of antiviral therapeutics. 
